|
|
Volumn 12, Issue 6, 2015, Pages 1701-1702
|
|
Antibody-Drug Conjugates (ADCs): Magic bullets at last!
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY CONJUGATE;
ANTINEOPLASTIC AGENT;
B LYMPHOCYTE ANTIGEN;
COLTUXIMAB RAVTANSINE;
VEDOTIN;
ANILINE DERIVATIVE;
ANTISERUM;
AZO COMPOUND;
CHLORAMBUCIL;
CHLORMETHINE DERIVATIVE;
FLUOROURACIL;
IMMUNOGLOBULIN;
MERCAPTOPURINE;
METHOTREXATE;
TETRACYCLINE;
THIOTEPA;
URAMUSTINE;
ANTIBODY DRUG CONJUGATE;
BREAST CANCER;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CONJUGATE;
DRUG CONJUGATION;
DRUG DESIGN;
DRUG DISTRIBUTION;
EDITORIAL;
HUMAN;
LARGE CELL LYMPHOMA;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
TUMOR XENOGRAFT;
DIALYSIS;
MEDICINAL CHEMISTRY;
RESEARCH;
ULTRAVIOLET RADIATION;
6-MERCAPTOPURINE;
ANILINE COMPOUNDS;
AZO COMPOUNDS;
CHEMISTRY, PHARMACEUTICAL;
CHLORAMBUCIL;
DIALYSIS;
FLUOROURACIL;
GAMMA-GLOBULINS;
IMMUNE SERA;
METHOTREXATE;
NITROGEN MUSTARD COMPOUNDS;
RESEARCH;
TETRACYCLINE;
THIOTEPA;
ULTRAVIOLET RAYS;
URACIL MUSTARD;
|
|
EID: 84930665860
PISSN: 15438384
EISSN: 15438392
Source Type: Journal
DOI: 10.1021/acs.molpharmaceut.5b00302 Document Type: Editorial |
|
Times cited : (33)
|
|
References (6)
|
